RI H5679 | 2023 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 10-0)
Status: Introduced on February 17 2023 - 25% progression, died in committee
Action: 2023-03-15 - Committee recommended measure be held for further study
Pending: House Health & Human Services Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 17 2023 - 25% progression, died in committee
Action: 2023-03-15 - Committee recommended measure be held for further study
Pending: House Health & Human Services Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name on list.
Title
The Prescription Drug Sales Representative Disclosure Act
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-03-15 | House | Committee recommended measure be held for further study |
| 2023-03-10 | House | Scheduled for hearing and/or consideration (03/15/2023) |
| 2023-02-17 | House | Introduced, referred to House Health & Human Services |
Rhode Island State Sources
| Type | Source |
|---|---|
| Summary | https://status.rilegislature.gov/ |
| Text | https://webserver.rilegislature.gov/BillText23/HouseText23/H5679.pdf |
